Experts discuss the use of artificial intelligence (AI) and patient-centric strategies in oncology clinical trials.

With the goal to become a top 3 pharma company in China, Novartis has been busy tapping into the expertise of local ...

Loomis Sayles, an investment management company, released its “Global Growth Fund” first quarter 2025 investor letter. A copy ...

This browser is no longer supported at MarketWatch. For the best MarketWatch.com experience, please update to a modern browser.

Steven H. Stein currently works at Repare Therapeutics, Inc., as Director from 2024, Incyte Corp., as Chief Medical Officer & Executive Vice President from 2016, the University of Pennsylvania, as ...